Šribar et al. used the previously established approach consisting of structure-and pharmacophore-based computational studies followed up by experimental validation to find novel inhibitors of TLR8. They performed two rounds of VS. The authors used the best hit from the first round of VS and performed its optimisation by shape-and chemistry-based screening.